Chemical Structure : TAK-960
CAS No.: 1137868-52-0
货号: PC-25813Not For Human Use, Lab Use Only.
TAK-960 is a potent, selective, ATP-competitive, orally available inhibitor of polo-like kinase 1 (PLK1) with IC50 of 1.6 nM in TR-FRET assays.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | ¥980 | In stock | |
| 10 mg | ¥1480 | In stock | |
| 25 mg | ¥2580 | In stock | |
| 50 mg | Get quote | ||
| 100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
TAK-960 is a potent, selective, ATP-competitive, orally available inhibitor of polo-like kinase 1 (PLK1) with IC50 of 1.6 nM in TR-FRET assays.
TAK-960 inhibits full-length PLK1 protein with IC50 of 0.8 nM, relatively inhibits PLK2 and PLK3 with IC50 of 16.9 and 50.2 nM, weakly inhibits FAK, MLCK, and FES kinases against a panel of 288 kinases.
TAK-960 (10-30 nM) induces accumulation of aberrant mitotic cells in HT-29 cells.
TAK-960 inhibits proliferation of human cancer cell lines regardless of TP53 and KRAS mutation and MDR1 expression status.
TAK-960 treatment caused accumulation of G2–M cells, aberrant polo mitosis morphology, and increased phosphorylation of histone H3 (pHH3) in vitro and in vivo.
TAK-960 inhibits proliferation of multiple cancer cell lines, with mean EC50 values ranging from 8.4 to 46.9 nM, but not in nondividing normal cells.
TAK-960 significantly inhibited the growth of HT-29 colorectal cancer xenografts, exhibited significant efficacy against multiple tumor xenografts, including an adriamycin/paclitaxel-resistant xenograft model and a disseminated leukemia model.
| 分子量 | 561.61 | |
| 分子式 | C27H34F3N7O3 | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
4-((9-Cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino)-2-fluoro-5-methoxy-N-(1-methylpiperidin-4-yl)benzamide |
|
1. Hikichi Y, et al. Mol Cancer Ther. 2012 Mar;11(3):700-9.
2. Nie Z, et al. Bioorg Med Chem Lett. 2013 Jun 15;23(12):3662-6.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright